Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
3
4
5
6
7
8
9
Next >
2 Biotech Stocks to Buy Hand Over Fist in April
April 06, 2024
Tickers
AMGN
SRPT
Tags
Recent Press Releases
AMGN
Market News
From
Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Tickers
CI
ITCI
JANX
JNJ
Tags
VKTX
JNJ
CI
From
Benzinga
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
March 13, 2024
Tickers
RGNX
SRPT
Tags
Market News
SRPT
RGNX
From
Motley Fool
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
Tickers
NEWS
PFE
RGNX
SRPT
Tags
Upgrades
General
News
From
Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
March 08, 2024
Tickers
ENPH
GOOG
GOOGL
SRPT
Tags
Recent Press Releases
GOOGL
GOOG
From
Motley Fool
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
March 04, 2024
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
February 29, 2024
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Sarepta Therapeutics: Q4 Earnings Insights
February 28, 2024
Tickers
SRPT
Tags
Benzinga
Earnings
Market News
From
Benzinga
Is It Too Late to Buy Sarepta Therapeutics Stock?
February 28, 2024
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Earnings Scheduled For February 28, 2024
February 28, 2024
Tickers
NOVT
NRG
NSA
NTNX
Tags
STN
VLN
PERF
From
Benzinga
A Preview Of Sarepta Therapeutics's Earnings
February 27, 2024
Tickers
SRPT
Tags
Benzinga
Earnings
Market News
From
Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Tickers
CRSP
NEWS
REGN
SRPT
Tags
Briefs
News
General
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Tickers
ARQT
IOVA
LLY
MDT
Tags
BZI/AUOA
VTGN
VKTX
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Tickers
AMIX
AMN
AORT
BCLI
Tags
CLDI
AORT
HEPA
From
Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Tickers
NEWS
RHHBY
SRPT
Tags
General
RHHBY
Movers
From
Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 16, 2024
Tickers
AMAT
AMBO
AMN
AORT
Tags
Movers
Top Losers
Markets
From
Benzinga
Why Sarepta Therapeutics Stock Is Soaring Today
February 16, 2024
Tickers
SRPT
Tags
Market News
SRPT
Recent Press Releases
From
Motley Fool
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
Tickers
AMAT
AORT
BIO
BLZE
Tags
KNSL
Intraday Update
Market News
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Tickers
AMN
AORT
CDIO
HCTI
Tags
BZI/TFM
CDIO
MNOV
From
Benzinga
In-Depth Examination Of 13 Analyst Recommendations For Sarepta Therapeutics
February 15, 2024
Tickers
SRPT
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
2 Magnificent Growth Stocks to Buy With $500
February 15, 2024
Tickers
SRPT
VEEV
Tags
VEEV
Recent Press Releases
Market News
From
Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
Tickers
DNLI
NEWS
PFE
RGNX
Tags
Expert Ideas
Analyst Color
RGNX
From
Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
February 11, 2024
Tickers
PTCT
SRPT
Tags
PTCT
Recent Press Releases
Market News
From
Motley Fool
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Tickers
ADP
AJG
AMGN
AMH
Tags
Market News
ILMN
Stocks to Buy
From
InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
January 30, 2024
Tickers
SRPT
Tags
SRPT
Market News
Analyst Ratings
From
Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
January 29, 2024
Tickers
NEWS
SRPT
Tags
General
Health Care
Large Cap
From
Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
January 26, 2024
Tickers
SRPT
SYM
UBER
Tags
Recent Press Releases
SYM
Market News
From
Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
January 25, 2024
Tickers
SRPT
VRTX
Tags
VRTX
Recent Press Releases
SRPT
From
Motley Fool
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
January 22, 2024
Tickers
JPM
SRPT
Tags
Market News
SRPT
JPM
From
Motley Fool
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
Tickers
ATOS
SRPT
UTHR
Tags
Market News
UTHR
Hot Stocks
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.